Clinical Trial Update: The Comparative Clinical Study of Gamisoyosan on Anxiety of Generalized Anxiety Disorder According to Dosage Form [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Gamisoyosan for generalized anxiety disorder has completed, comparing different dosage forms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• Gamisoyosan (Gamisoyosan)

Snippet

Sponsor: Korea Health Industry Development Institute | Conditions: Generalized Anxiety Disorder | Phase 3 | Status: COMPLETED